Рrospective multicenter study of treatment efficacy, safety, and quality of life in a large cohort of patients with inborn errors of immunity receiving subcutaneous immunoglobulin by the rapid push method
Front Immunol. 2025 Jul 22;16:1598491. doi: 10.3389/fimmu.2025.1598491. eCollection 2025. ABSTRACT Subcutaneous immunoglobulin (SCIG) preparations are widely used in patients with inborn errors of immunity (IEI), …